Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

NCT07224880 · clinicaltrials.gov ↗

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

glp1 Agonist
Gene Expression
Skin Laxity

Interventions

DEVICE: ellacor

Sponsor

Cytrellis Biosystems, Inc.